NCT07556367Active, not recruiting
Post-Radiation Oral Health in Underserved Head and Neck Cancer Patients
Source: ClinicalTrials.gov · Last updated 1 Jun 2026
Brief summary (registry, in English)
This is a pilot study evaluates the feasibility and outcomes of providing fluoride varnish treatment during routine cancer surveillance visits for post-radiation head and neck cancer patients with limited access to dental care.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 43 (actual)
- First submitted
- 22 Apr 2026
- Start date
- 1 Oct 2024
- Primary completion date
- 30 Nov 2026
- Lead sponsor
- University of California, San Francisco
- Diseases
- Head and neck cancer
- NCT number
- NCT07556367
What you commit to
- Study type: Interventional
- Participants enrolled: 43
- From 1 Oct 2024 to the primary completion date, 30 Nov 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- \>18 years old.
Other
- Patients, caregivers, health and dental care providers who are able to provide their own informed written consent.
Who the study is looking for
- \>18 years old who are uninsured or underinsured (MediCal, Healthy SF) or have full coverage.
- Patients who have received immunotherapy or enhanced chemotherapy regimens.
- Patients or health and dental care providers who are able to provide their own informed written consent.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Zuckerberg San Francisco General Hospital (ZSFG) Coordinator of this site? Confirm its status | San Francisco | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.